![Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-021-09710-8/MediaObjects/10434_2021_9710_Fig1_HTML.png)
Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
![Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2022/op.2022.18.issue-3/op.21.00482/20220303/images/large/op.21.00482t1.jpeg)
Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice
![It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn](https://cdn.mdedge.com/files/s3fs-public/obgm03210-pearlman_web_t1.jpg)
It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn
![Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study | British Journal of Cancer Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.222/MediaObjects/41416_2015_Article_BFbjc2015222_Fig1_HTML.jpg)
Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study | British Journal of Cancer
![Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection](https://connection.asco.org/sites/asco_connection/files/styles/article_image/public/articles/images/JCO-BC-risk-01_747x556.png?itok=cPe2DoDV)
Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub](https://www.pdffiller.com/preview/428/167/428167845/large.png)
The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096097762101002X-gr1.jpg)
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect
![Preventing Breast Cancer Through Identification and Pharmacologic Management of High-Risk Patients - Mayo Clinic Proceedings Preventing Breast Cancer Through Identification and Pharmacologic Management of High-Risk Patients - Mayo Clinic Proceedings](https://www.mayoclinicproceedings.org/cms/asset/d5dcdfcd-30bf-490e-a20a-b944f302b84a/gr1.jpg)
Preventing Breast Cancer Through Identification and Pharmacologic Management of High-Risk Patients - Mayo Clinic Proceedings
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer - Document - Gale OneFile: Health and Medicine
![Frontiers | A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes Frontiers | A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes](https://www.frontiersin.org/files/Articles/640268/fonc-11-640268-HTML/image_m/fonc-11-640268-g001.jpg)
Frontiers | A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
![Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879406819303534-gr1.jpg)